See what professionals say about their NOVOS partnership experience.
As the founder of Wellgevity, I value science-backed solutions that truly enhance patient care. NOVOS Core has been an excellent partner in our pursuit of longevity and optimal health. This research-driven product seamlessly aligns with our mission by tackling the root pathways driving aging. NOVOS Core acts as an insurance policy against future disease by boosting energy, improving cognition, and promoting overall well-being. Together, we’re making meaningful strides in longevity medicine.
Dr. Tamsin Lewis, MD, Wellgevity
At Elite Medical Associates, our goal is to maximize healthspan through science-backed interventions. NOVOS stands out as a thoughtfully formulated longevity supplement grounded in current aging research. We’ve incorporated it into our cellular health protocols with strong patient engagement and observed improvements in energy and focus. We are actively monitoring biomarkers and changes in other functional metrics. It aligns well with our mission to practice proactive, evidence-guided medicine.
Manoj K. Sharma, DO – Founder of Elite Medical Associates, Concierge Longevity Medicine – Board Certified Internal Medicine, Department Chair of Internal Medicine Sunrise Hospital Medical Center
Our professional relationship with NOVOS has been instrumental in advancing human longevity. NOVOS’s innovative approach to longevity medicine complements Hydrology Wellness’s commitment to enhancing patient care with safe and effective formulations and biological age tests. By integrating NOVOS’s cutting-edge insights and supplements, we are able to offer our patients comprehensive, science-backed solutions that contribute significantly to their overall well-being and longevity.
Lorrie Althage, MSN, APRN, FNP-C, DOT-CME, CCRN, Hydrology Wellness
As a health coach, I teach and counsel my patients on nutrition and longevity. The NOVOS products are a valuable tool to provide, at the cellular level, nutrition to repair and renew. I have been taking the products and have clarity and energy to continue my practice. My patients have noticed my skin glowing and my added energy.
Carolyn Travers, Certified Health and Wellness Coach, Ideal Body and Wellness Center
To achieve a better look is just one side of the equation. NOVOS is the perfect complement for an inside treatment. Our patients love the combination of taking NOVOS with our skin rejuvenation / skin healing treatments. We also use it in combination to boost our muscle stimulation or mimic fasting results. Patients who take NOVOS report a better general energy, ability to concentrate and improved skin condition. We offer several different nutrition supplements in our practice, whereof NOVOS is the most consumed one. We Love NOVOS.
Caroline Prenn, Founder, Medical Aesthetics Switzerland
As an anti-aging MD, I encourage all my patients to use NOVOS products as their basic buy blocks to augment lifestyle changes. The information provided by NOVOS is exceptional and the ingredients are well researched and documented. I use all 3 of their supplements and find their aging clock to be reasonably priced and the explanation very user friendly! The company is very responsive to questions and provides solutions to logistical and other issues.
Dr. Jeffrey Passer, MD, Passer Restorative Therapies
As functional medicine experts and leaders in the health and wellness industry, Liquivida® is dedicated to helping clients achieve optimal health and their longevity goals. NOVOS’ scientifically-backed products align perfectly with Liquivida®’s mission and values, offering effective solutions for minimizing the impacts of aging, increasing energy and enhancing cognition. NOVOS products perfectly complement the services and modalities Liquivida® offers to help our clients feel and look their best.
Dr. Christopher Davis, MD, Liquivida
A selection of NOVOS partners
Daily Foundation
Start here
NOVOS Core
12 HallmarksOne daily drinkHuman clinical trial
Comprehensive daily support for energy, sleep, focus, and whole-body resilience—targeting all 12 Hallmarks of Aging.
NOVOS is the scientific leader in longevity with a mission to add a billion years of healthy life to humanity by making the latest scientific advances in longevity accessible and achievable by all.
The Results Speak for Themselves
NOVOS formulas are backed by 950+ studies and ongoing independent laboratory studies. Learn how NOVOS has helped others and how we can help you.
Prolong your lifespan with our expertise in Longevity
NOVOS’ Scientific and Medical advisory teams are composed of world-renowned, leading thinkers from institutions like Harvard Medical School, MIT, the Salk Institute, National University of Singapore, and more.
Dr. George Church, PhD
Harvard Medical School & MIT Professor
“100 most influential people: ‘His contribution to genetic research and the imagination he brings to its application may change the entire world and our experience of life itself.’ ” –
Also featured in:
Dr. George Church published the first direct genomic sequencing method in 1984 and is known as the “father” of synthetic biology and personalized genomics. Dr. Church has received various accolades, which include election to the National Academy of Sciences and the National Academy of Engineering. He is a recipient of the American Society for Microbiology Promega Biotechnology Research Award. His most cited work has been published in peer reviewed scientific journals including PNAS, Nature Genetics, Nature Biotechnology, Science, the Journal of Molecular Biology, Nature, and many others.
Dr. Pamela Maher, PhD
University of British Columbia, Salk Institute for Biological Studies
“Maher was one of the first to take aging into account for drug discovery in Alzheimer’s. She identified a class of compounds known as geroneuroprotectors, which slow the aging process in mice.” –
Dr. Maher worked for 5 years as an assistant professor at the Whittier Institute for Diabetes and Endocrinology in La Jolla, CA, then moved to The Scripps Research Institute in 1994 as an associate professor. In 2004, she moved to her current position at The Salk Institute. Her research interests focus on using natural products such as flavonoids, small molecules that are widely distributed in fruits and vegetables, to maintain nerve cell function in the presence of toxic insults, especially in relation to Alzheimer’s, dementia & Parkinson’s.
Dr. J Pedro de Magalhaes, PhD
Harvard Medical School, University of Birmingham
“I think that having the genome sequence of the bowhead whale will allow researchers to study basic molecular processes and identify maintenance mechanisms that help preserve life, avoid entropy and repair molecular damage.” –
Also featured in:
Dr. de Magalhaes leads the Integrative Genomics of Aging Group at the Institute of Integrative Biology, University of Liverpool, UK. Dr. de Magalhaes completed his postdoc with genomics pioneer, Dr. George Church, at Harvard Medical School. He developed high-throughput approaches for studying aging, including computational tools and databases, statistical models of mortality, and comparative genomics methods for investigating the evolution of longevity. Dr. de Magalhaes maintains several databases related to the impact that drugs & natural substances have on aging.
Dr. Oliver Medvedik, PhD
Harvard Medical School, The Cooper Union
“Medvedik and his colleagues want to help people enjoy good health for as long as possible […] With aging research, Medvedik has his eyes on the long run” –
Director of the Kanbar Center for Biomedical Engineering, Cooper Union. Dr. Medvedik has worked as a biotechnology consultant at Sirtris Pharmaceuticals and has taught molecular and synthetic biology while at Harvard University, The Cooper Union, School of Visual Arts, Genspace and NYU. He is also co-founder and vice-president of the non-profit organization LEAF (Life Extension Advocacy Foundation), where he serves on the board of directors. Dr. Medvedik performed his doctoral research at Dr. David Sinclair’s Harvard lab, and is a coauthor on multiple papers including studies on NAD+ and calorie restriction.
Dr. Avi Rosenbaum, PhD
Harvard Medical School
“Avi has a Ph.D. from Harvard University where in the lab of Professor George Church he developed technologies for sequencing and interpreting human genomes.” –
Scientist and Consultant, with deep knowledge of the biotech industry. Experience and international network in Genomics, Personalized Medicine, Gene Therapy and Synthetic Biology. Built the first academic Next Generation Sequencing platform. Launched more than ten commercial products. Investor and mentor in biotech, pharma, medical and food-tech companies. Holder of five patents, and co-author of high-profile academic publications with over 2,500 citations.
Dr. Robert Lufkin, MD
USC School of Medicine
Dr. Lufkin is Chief of Metabolic Imaging at a medical network in California and a distinguished Professor of Radiology at the USC School of Medicine, with over 200 peer-reviewed scientific papers to his credit and 14 books published. Dr. Lufkin has held several prestigious professional affiliations, including the presidency of the Society of Magnetic Resonance Imaging and the American Society of Head and Neck Radiology. He is also the inventor of several patents in artificial intelligence, including the globally-used MR-compatible biopsy needle, the “Lufkin Needle.”
Dr. Matt Kaeberlein, PhD
Massachusetts Institute of Technology, University of Washington — Consultant
Professor of Pathology, Adjunct Professor of Genome Sciences, and Adjunct Professor of Oral Health Sciences at the University of Washington, Dr. Kaeberlein’s research interests focus on basic mechanisms of aging in order to identify interventions that promote healthspan and improve quality of life. He has published nearly 200 papers in top scientific journals and has been recognized by prestigious awards, including Breakthroughs in Gerontology, Alzheimer’s Association Young Investigator Award, Ellison Medical Foundation New Scholar in Aging, a Murdock Trust Award, Pioneer in Aging, and Vincent Cristofalo Rising Star in Aging Research.
A commitment beyond commerce
NOVOS is a Public Benefit Corporation, legally committed to balancing profit with purpose: advancing human health, longevity research, and public education alongside commercial success.
We donate a portion of profits and equity to nonprofits advancing longevity research, including the Lifespan Research Institute (LRI), and support initiatives like the Dog Aging Project — helping dogs live longer, healthier lives while accelerating insights into human aging.
These statements have not been evaluated by the Food and Drug Administration. This product/information is not intended to diagnose, treat, cure, or prevent any disease.
NOVOS Insider
We’ve got you covered
Go beyond the longevity solutions and get an insider view of the latest breakthrough science. NOVOS is a Public Benefit Corporation that provides science-based tips, actionable guidance, and expert-backed tools to the public for free.
Join our NOVOS community today to be Younger For Longer!
This site uses cookies to improve your experience.
Also featured in: 
Dr. George Church published the first direct genomic sequencing method in 1984 and is known as the “father” of synthetic biology and personalized genomics. Dr. Church has received various accolades, which include election to the National Academy of Sciences and the National Academy of Engineering. He is a recipient of the American Society for Microbiology Promega Biotechnology Research Award. His most cited work has been published in peer reviewed scientific journals including PNAS, Nature Genetics, Nature Biotechnology, Science, the Journal of Molecular Biology, Nature, and many others.
Dr. Maher worked for 5 years as an assistant professor at the Whittier Institute for Diabetes and Endocrinology in La Jolla, CA, then moved to The Scripps Research Institute in 1994 as an associate professor. In 2004, she moved to her current position at The Salk Institute. Her research interests focus on using natural products such as flavonoids, small molecules that are widely distributed in fruits and vegetables, to maintain nerve cell function in the presence of toxic insults, especially in relation to Alzheimer’s, dementia & Parkinson’s.
Also featured in: 
Dr. de Magalhaes leads the Integrative Genomics of Aging Group at the Institute of Integrative Biology, University of Liverpool, UK. Dr. de Magalhaes completed his postdoc with genomics pioneer, Dr. George Church, at Harvard Medical School. He developed high-throughput approaches for studying aging, including computational tools and databases, statistical models of mortality, and comparative genomics methods for investigating the evolution of longevity. Dr. de Magalhaes maintains several databases related to the impact that drugs & natural substances have on aging.
Director of the Kanbar Center for Biomedical Engineering, Cooper Union. Dr. Medvedik has worked as a biotechnology consultant at Sirtris Pharmaceuticals and has taught molecular and synthetic biology while at Harvard University, The Cooper Union, School of Visual Arts, Genspace and NYU. He is also co-founder and vice-president of the non-profit organization LEAF (Life Extension Advocacy Foundation), where he serves on the board of directors. Dr. Medvedik performed his doctoral research at Dr. David Sinclair’s Harvard lab, and is a coauthor on multiple papers including studies on NAD+ and calorie restriction.
Scientist and Consultant, with deep knowledge of the biotech industry. Experience and international network in Genomics, Personalized Medicine, Gene Therapy and Synthetic Biology. Built the first academic Next Generation Sequencing platform. Launched more than ten commercial products. Investor and mentor in biotech, pharma, medical and food-tech companies. Holder of five patents, and co-author of high-profile academic publications with over 2,500 citations.
